T&R Biofab Co., Ltd. (KOSDAQ:246710)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Medical Engineering Devices Division	4.87B	5.20B
Medical Engineering Devices Division Growth	-6.26%	-
Total	4.87B	5.20B
Total Growth	-6.26%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
South Korea	4.33B	4.61B
South Korea Growth	-6.18%	-
Vietnam	298.06M	462.15M
Vietnam Growth	-35.51%	-
USA	25.06M	150.17K
USA Growth	16587.44%	-
Philippines	162.75M	82.51M
Philippines Growth	97.25%	-
Japan	30.74M	18.10M
Japan Growth	69.78%	-
Taiwan	12.82M	20.35M
Taiwan Growth	-37.02%	-
Europe	14.50M	1.15M
Europe Growth	1156.70%	-
Total	4.87B	5.20B
Total Growth	-6.26%	-

Source: S&P Global Market Intelligence.